A Message from
Kaitlyn Proulx
Managing Director, PDCI Market Access

I am thrilled to be sharing the news of the recent acquisition of PDCI Market Access by McKesson Canada Corporation.

Over the years, PDCI has continued to grow and thrive as a trusted strategic pricing and reimbursement partner for Canadian pharmaceutical manufacturers. We are proud to be Canada’s leading market access consultancy with core competencies and expertise in pricing, reimbursement, and health economics.

As a distinct business unit operating within the larger McKesson family, PDCI will continue to develop and expand its current services and expertise, while leveraging the broader capabilities of McKesson Canada. Together, we will continue to provide end-to-end solutions to support manufacturer needs. We aim to remove barriers when introducing and launching innovative products in Canada, ultimately benefitting patient outcomes and improving Canada’s drug supply.

To our highly valued clients, rest assured your day-to-day business contacts and support levels will remain the same at PDCI. From that perspective, it is business as usual for PDCI and its clients.  

We are excited about this next chapter and the new opportunities for PDCI, our clients and partners.  I am available to answer questions and address any concerns arising from the news of this acquisition. Please do not hesitate to reach me at Kaitlyn.Proulx@pdci.ca.

Sincerely,

Kaitlyn Proulx,
Managing Director,
PDCI Market Access